Wetzel Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Hold
11,256
4.68% 5
2026
Q1
$10.4M Buy
11,256
+410
+4% +$416K 4.12% 8
2025
Q4
$11.7M Buy
10,846
+1,176
+12% +$1.12M 4.72% 7
2025
Q3
$7.38M Buy
9,670
+8
+0.1% +$5.95K 3.15% 8
2025
Q2
$7.53M Buy
9,662
+2
+0% +$1.55K 3.44% 8
2025
Q1
$7.98M Buy
9,660
+21
+0.2% +$17.5K 4.02% 5
2024
Q4
$7.44M Buy
9,639
+83
+0.9% +$68.7K 3.7% 5
2024
Q3
$8.47M Buy
9,556
+108
+1% +$97.1K 4.26% 5
2024
Q2
$7.35M Buy
9,448
+85
+0.9% +$68K 4.2% 4
2024
Q1
$6.98M Sell
9,363
-223
-2% -$159K 4.11% 4
2023
Q4
$5.59M Buy
+9,586
New +$5.6M 3.43% 5

Other funds holding LLY

Wetzel Investment Advisors's LLY Position: Q2 2026 in Review

Wetzel Investment Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 11,256 shares worth $13.5M. The position accounts for 4.68% of the portfolio, ranked #5.

Wetzel Investment Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wetzel Investment Advisors held 11,256 shares of Eli Lilly worth $13.5M as of Q2 2026.
  • Wetzel Investment Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 4.68% of Wetzel Investment Advisors's portfolio in Q2 2026, its #5 holding.
  • Wetzel Investment Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wetzel Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.